Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-01-17
1978-11-14
Moyer, Donald B.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 31195
Patent
active
041256263
ABSTRACT:
The synthesis of L-.gamma.-glutamyl-DOPA (L-.gamma.-glutamyl-L-3,4-dihydroxy-phenylalanine) and its use selectively to increase renal blood flow in mammals.
REFERENCES:
patent: 3676492 (1972-07-01), Biel et al.
patent: 3769424 (1973-10-01), Bayne
patent: 3803120 (1974-04-01), Felix
patent: 3939253 (1976-02-01), Bodor
patent: 3947590 (1976-03-01), Kynel et al.
Christenson et al., Archives of Biochemistry & Biophysics, vol. 141, pp. -367 (1970).
Orlowski et al., Acta Biochemica Polonica, vol. VIII, No. 2 (1961), pp. 189-200.
Orlowski, Archivum Immanolograe et Therapiae Experimentalis, 1963, vol. 11, pp. 1-61.
International Encyclopedia of Pharmacology & Therapeutics, vol. 1, published by Pergamon Press, N.Y. (1974), pp. 82-84.
Orlowski Marian
Wilk Sherwin
Moyer Donald B.
Mt. Sinai School of Medicine of the City University of New York
LandOfFree
Synthesis and use of L-.gamma.-glutamyl-DOPA does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthesis and use of L-.gamma.-glutamyl-DOPA, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthesis and use of L-.gamma.-glutamyl-DOPA will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1301666